These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26579772)

  • 21. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
    Plazinska A; Kolinski M; Wainer IW; Jozwiak K
    J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand induced change of β2 adrenergic receptor from active to inactive conformation and its implication for the closed/open state of the water channel: insight from molecular dynamics simulation, free energy calculation and Markov state model analysis.
    Bai Q; Pérez-Sánchez H; Zhang Y; Shao Y; Shi D; Liu H; Yao X
    Phys Chem Chem Phys; 2014 Aug; 16(30):15874-85. PubMed ID: 24962153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to deal with multiple binding poses in alchemical relative protein-ligand binding free energy calculations.
    Kaus JW; Harder E; Lin T; Abel R; McCammon JA; Wang L
    J Chem Theory Comput; 2015 Jun; 11(6):2670-9. PubMed ID: 26085821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures.
    Yau MQ; Emtage AL; Chan NJY; Doughty SW; Loo JSE
    J Comput Aided Mol Des; 2019 May; 33(5):487-496. PubMed ID: 30989574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Streamlined, General Approach for Computing Ligand Binding Free Energies and Its Application to GPCR-Bound Cholesterol.
    Salari R; Joseph T; Lohia R; Hénin J; Brannigan G
    J Chem Theory Comput; 2018 Dec; 14(12):6560-6573. PubMed ID: 30358394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
    Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
    Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of the orthosteric ligands binding on the conformational dynamics of the B-2-adrenergic receptor by means of essential dynamics sampling simulation].
    Novikov GV; Sivozhelezov VS; Shaitan KV
    Mol Biol (Mosk); 2014; 48(3):463-79. PubMed ID: 25831896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.
    Woo AY; Song Y; Zhu W; Xiao RP
    Br J Pharmacol; 2015 Dec; 172(23):5477-88. PubMed ID: 25537131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energy Landscapes Reveal Agonist Control of G Protein-Coupled Receptor Activation via Microswitches.
    Fleetwood O; Matricon P; Carlsson J; Delemotte L
    Biochemistry; 2020 Feb; 59(7):880-891. PubMed ID: 31999436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating Ligand-Modulated Conformational Landscape of GPCRs Using Cloud-Computing Approaches.
    Shukla D; Lawrenz M; Pande VS
    Methods Enzymol; 2015; 557():551-72. PubMed ID: 25950981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
    Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
    Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol-β1 AR interaction versus cholesterol-β2 AR interaction.
    Cang X; Yang L; Yang J; Luo C; Zheng M; Yu K; Yang H; Jiang H
    Proteins; 2014 May; 82(5):760-70. PubMed ID: 24265091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of the ligand-induced spatiotemporal residue pair pattern of β2-adrenergic receptors using 3-D residual networks trained by the time series of protein distance maps.
    Han M; Lee S; Ha Y; Lee JY
    Comput Struct Biotechnol J; 2022; 20():6360-6374. PubMed ID: 36420156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-based assays and molecular dynamics analysis of a boron-containing agonist with different profiles of binding to human and guinea pig beta2 adrenoceptors.
    Soriano-Ursúa MA; Bello M; Hernández-Martínez CF; Santillán-Torres I; Guerrero-Ramírez R; Correa-Basurto J; Arias-Montaño JA; Trujillo-Ferrara JG
    Eur Biophys J; 2019 Jan; 48(1):83-97. PubMed ID: 30386878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.